Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of attention-deficit/hyperactivity disorder (ADHD) and in the management of narcolepsy. It works by increasing the levels of norepinephrine and dopamine in the brain. Strattera is approved by the FDA to treat ADHD and narcolepsy in adults ages 18 years and older.
Strattera works by targeting the reuptake of norepinephrine and dopamine in the brain and thus blocking the effects of these chemicals.
This medication falls under the category of non-stimulant medications and has a long history of use in the treatment of ADHD. Strattera was approved by the FDA in 1999 for the treatment of ADHD, and it has become one of the most prescribed medications in the world. It is one of the most prescribed medications in the US and is used by more than 200,000 patients over the past 15 years. Strattera is not a stimulant medication and is considered to be a non-stimulant.
Strattera should be taken as directed by your doctor, usually once or twice a day depending on the dose prescribed by your doctor. Your doctor may start you on a low dose of Strattera and gradually increase it.
In clinical trials, the average starting dose for adults with ADHD in the first year was 80 mg/day (one-fourth full-dose, 30 to 60 mg). The effects of the medication on patients with ADHD can last anywhere from 6 to 8 weeks.
If you have been taking Strattera for 3 to 4 months or are on maintenance doses, your doctor may adjust your dose.
For most people, the standard dose is 40 mg/day (two-third full-dose, 20 to 30 mg). Your doctor may also recommend that you take a lower dose, based on your age, body weight and your response to the medication.
The maximum daily dose of Strattera is 60 mg/day (five to seven-quarters full-dose, 60 to 80 mg). Your doctor may decrease your dose from 60 mg/day (two to three-quarters full-dose, 40 to 60 mg) to 25 mg/day (one-half full-dose, 40 to 60 mg) based on your condition and response to the medication.
Most people who take Strattera do not experience any side effects at all. The most common side effects include:
If you experience any of the side effects, contact your doctor immediately.
There is not enough information to determine which medications can interact with Strattera. It is important to inform your doctor of all the medications you are currently on, including prescription drugs, over-the-counter medications, vitamins and herbal supplements, and recreational drugs. Strattera should not be used to treat ADHD unless the doctor has discussed it with you.
The most common interactions are:
ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) TABLETS:Azoetic Acid
is used to treat ADHD in children and adolescents ages 4-17. In adults, it is used to increase attention and focus.
ACTIVE INGREDIENT
Atomoxetine Hydrochloride: 10 mg
100 mg
Active Ingredients:
Non-Prescription Use:Not for use by prescription.
Secondary Uses:Attention Deficit Hyperactivity Disorder (ADHD): increases concentration, improves attention, and helps with concentration problems in adults.
Terms and Conditions:This product is for use in adults only and is not for use in children or adolescents.
DOSAGE AND ADMINISTRATION
Initial dose:100 mg/day (max 100 mg) as needed, preferably during the first 2 weeks of treatment. Continue for 6 weeks.
Maintenance dose:
Treatment Duration:This medicine is not for use in children or adolescents.
Storage:Store at room temperature.
Product Substitutes:Other medications should not be used for the treatment of ADHD, as they can interfere with the effectiveness of this product.
Manufacturer/Marketer:Azoetic Acid manufacturer: Atomoxetine Hydrochloride, India.
Country of Origin:USA.
Associate Member:Sun Pharma Pharmaceutical Ltd.
Specialty Drugs:Hemodialysis
Additional Product Manufacturers/Brand/Source:Aurochem
Established:2010
Recently Addressed:24/11/2014
ATOMOXETINE TABLETS
ATOMOXETINE is used to treat attention deficit hyperactivity disorder (ADHD) in children ages 4-17.
Atomoxetine tablets (Atomoxetine Hydrochloride) are used to treat ADHD in adults and children ages 4-17.
Conditions Treated:ADHD: increases concentration, improves attention, and helps with concentration problems in adults.
Therapeutic Uses:This medication is used to treat attention deficit hyperactivity disorder (ADHD) in children ages 4-17.
Atomoxetine is used to treat attention deficit hyperactivity disorder (ADHD) in adults.
ATOMOXETINE Tablets: 10 mg
ATOMOXETINE is used to treat ADHD in adults ages 4-17.
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is a prescription drug containing the active ingredient atomoxetine. The Food and Drug Administration (FDA) of 2023 strictly prohibits the disclosure of the identity, composition, and dosage of medication.
Strattera is a prescription drug that may also be used as a treatment or. It is not indicated for use without doctor’s prescription.
Lilly and company began marketing Strattera in 2002 through independent pharmaceutical manufacturer Tellazapine. In 2009, the company began offering generic Strattera without requiring a prescription. In 2010, the company began offering generic versions of the drug without a prescription. Strattera is indicated for the treatment of attention-deficit hyperactivity disorder (ADHD).
pregnancy. Lower doses of the drug may be used to achieve a more adequate dose of Strattera than is commercially feasible, Tellazapine writes.
Rosuvastatin calcium is a nonsteroidal anti-inflammatory drug (NSAID) that temporarily blocks the absorption of dietary cyclo-oxygenase (COX) products in the body. This reduces pain, inflammation, and swelling associated with asthma, chronic bronchitis, hypertension, and coldumers. Rosuvastatin is used to treat coronary artery disease and high blood pressure. It may be used alone or in combination with other medications to lower high blood pressure and treat symptoms of asthma or chronic bronchitis.
Adolescents (13 to 17 years) may be prompted to purchase prescription drugs after the COX-2 selective COX-2 inhibitors, including Adderall, Keppra, and Risperdal, have been discontinued by the manufacturer. The decision to discontinue the use of COX-2 inhibitors in adolescent is a matter of US and Canadian patent, and Lilly and its parent company, Eli Lilly, have never infringed this patent.
Lilly develops and directs educational and research efforts at international and high-quality academic institutions. The Indianapolis Star reports
Lilly, based in Tempe, Arizona, is a family-owned business that has a stable of over 2,500 businesses. In the United States, more than half of those institutions are accredited by the National Association of Boards of Adolescent Medicine (NABP). In the year to April 2023, NABP accreditation has been demonstrated for approximately 40 percent of organizations.
Lilly is the parent of Eli Lilly and Company, which has some 20 companies that have some connection with the company.
In addition to Lilly, the company has some other companies that have some connection with the company. In the year to April 2023, more than a dozen of these companies have some connection with the company. In the year to April 2023, these companies have more than 40 percent of the nation’s public businesspeople. In the year to April 2023, these companies have more than 200 million patients.
Lilly has no direct links to the United States, nor is there any connection between the companies. Lilly has no connection with the United States.
The most common company name associated with the purchase of prescription drugs is Pfizer Inc. Most countries have countries where Lilly is the largest commercial force. In the year to April 2023, more than a dozen pharmaceutical companies have some connection with Pfizer.
Pfizer Inc. is a division of Eli Lilly and Company that has some connection with Pfizer.
In addition to Pfizer, the company has some other companies that have some connection with the company.
has a direct relationship with two companies that have some connection with Pfizer.
has a direct relationship with one company that has some connection with Pfizer.
Strattera is a prescription medicine to treat patients with a mental disorder called attention-deficit hyperactivity disorder (ADHD). It belongs to a class of drugs called selective norepinephrine reuptake inhibitors and contains the active ingredient atomoxetine. It is used as a part of an ADHD treatment program which includes psychological, educational and social interventions. It is approved for use in adults and children above 6 years of age.
Strattera works by increasing the levels of d-arabitol (atomoxetine) in the body, a treatment for ADHD. The action of Strattera comes at the therapy level by inhibiting the reuptake of serotonin between neurons. This increases the amount of d-arabatitol that is available from the neurons for use as a treatment.
Strattera is consumed once a day with each main meal containing fat. It is important to follow the instructions given by your healthcare provider for the duration of treatment.Do notuse it after the last dose of Strattera, Instead, Take it as needed, every day for 4 weeks. The medicine is then absorbed into the cells and helps to increase d-arabatitol levels for use as a treatment for ADHD in the body.
Strattera is usually not recommended for use in children. If you have any concerns about how Strattera works for your child, please consult your doctor or pharmacist.
Strattera is usually recommended to use to treat ADHD in children. Be sure: Do not use it if you are allergic to atomoxetine or any other ingredients in the medication. It is not recommended to take it if you have had a heart attack, heart failure, or have had a stroke, because the effects can be severe.
Some common side effects of taking Strattera include drowsiness, vomiting, dizziness, upset stomach, fatigue, joint pain or swelling, and face and tongue pain. If these effects persist or worsen, consult your doctor or pharmacist. Do not use Strattera if you are pregnant or breastfeeding without consulting a doctor.
Some side effects of Strattera may disappear after you order the medication from us. In the event that you have any of the following concerns, you can contact us along with the United States of America. We offer a free review of our product selection and provide a full list of its risks and benefits.
Atomoxetine Law Firm
All men over 18 years of age have a right protected by legal expert consensus to make the decision to have and physically engage in sexual behaviour that is risky or treat your patient if the [attention-deficit-hypUnderactive disorder]. This is a potentially serious condition that can have a devastating effect on a man’s self-esteem and quality of life. The American Psychiatric Association (APA) has been writing to the U. S. Food and Drug Administration (FDA) to discuss the topic for potential FDA approval. The FDA is committed to protecting the health and safety of consumers.
D-Arabine is an ADHD medication. [attention deficit hyperactivity disorder]
Strattera works by increasing the levels of d-arabatitol (atomoxetine) into d-arabatine, a medication that helps a patient get and stay on top of their daily schedule. D-arabatine is a hormone that is released in the brain of a person who has ADHD. D-arabatine levels are considered high enough to be effective in treating ADHD. Strattera helps to increase the levels of d-arabatine that is available from neurons in the brain. This helps to treat ADHD in a patient who has ADHD.
The safety and efficacy of D-arabatitol in treating ADHD have been established in studies with children (aged 6 - 17 years).
D-arabatitol is considered a first-line treatment for ADHD.
Stade de France Pharmacy